Sunixar 12.5 mg Capsule
4.37$
3.96$
Sunixar 12.5 mg capsules are a potent anticancer medication designed to combat various malignancies, including pancreatic cancer, gastrointestinal stromal tumors, and renal cell carcinoma. This innovative treatment functions by inhibiting the proliferation of cancer cells, effectively slowing tumor growth and improving patient outcomes. Patients prescribed Sunixar should be aware of potential side effects, which may include fatigue, nausea, and risk of infection, making it crucial to monitor health closely during therapy. As with any cancer treatment, it’s essential to discuss your complete medical history with your healthcare provider to ensure safe and effective use. The administration of Sunixar requires careful adherence to prescribed dosages to maximize its therapeutic benefits. For those battling aggressive cancers, Sunixar 12.5 mg capsules represent a vital option in the ongoing fight against cancer, underscoring the importance of personalized treatment plans. Always consult your oncologist for tailored advice and support throughout your treatment journey.
الكمية
Active Pharmaceutical Ingredient
Uses
• Sunixar 12 5 mg capsule is indicated for the treatment of Advanced Renal Cell Carcinoma (RCC). This form of kidney cancer arises from the small tubes in the kidney and can progress rapidly. The medication helps inhibit tumor growth and can improve outcomes for patients with this condition. Utilizing Sunixar can provide a targeted approach to managing RCC effectively.
• Another significant use of Sunixar 12 5 mg capsule is in the treatment of Gastrointestinal Stromal Tumor (GIST). GIST is a rare cancer that develops in the digestive tract, primarily affecting the stomach and small intestine. By targeting specific cellular mechanisms, Sunixar aids in controlling the growth of these tumors. Patients diagnosed with GIST may benefit from the therapeutic effects of Sunixar as part of their treatment regimen.
• Sunixar 12 5 mg capsule is also effective for managing Pancreatic Neuroendocrine Tumors (PNETs). These tumors arise from the endocrine cells of the pancreas and are less common than other pancreatic cancers. The medication works by disrupting the pathways that facilitate tumor growth, thereby helping to control the disease. In cases of PNETs, Sunixar can play a crucial role in the overall treatment strategy.
• In summary, Sunixar 12 5 mg capsule serves multiple oncological applications, making it a versatile option for healthcare providers. It is primarily used to treat Advanced Renal Cell Carcinoma, Gastrointestinal Stromal Tumors, and Pancreatic Neuroendocrine Tumors. Each of these conditions represents a distinct challenge, and Sunixar offers a targeted therapy to enhance patient care. Its role in managing these specific cancers underscores its importance in oncological treatments.
Benefits
Sunixar 12.5 Capsule is used to treat specific forms of cancer, such as gastrointestinal stromal tumors (GISTs), renal cell carcinoma (RCC), and imatinib-resistant GIST. The advantages of using Sunixar may involve reducing the size of cancerous tumors, slowing the progression and spread of cancer, alleviating cancer-related symptoms, and potentially extending survival in some individuals.
Side Effects
Like all medicines, Sunixar 12.5 mg Capsule may cause side effects that do not require medical attention and that will disappear as your body adjusts to the medicine. Tell your doctor if they persist or if you're worried about them.
Most Common Side Effects
• Complete or Partial hair loss
• Change in hair and skin colour
• Back pain
• Stomach upset
• Dry skin
• Diarrhea
• Swollen eyes
• Tingling sensation in limbs
• Nausea and Vomiting
• Tiredness
• Muscle spasms
Common Side Effects
• Headache
• Blistered palm
• Rashes
• Sores mouth or tongue
• Bleeding
• Swollen and Painful limbs
• decreased vision
• Blood in stool

